Can i stop taking metformin
Searched over 200M research papers
Summary
6 papers analyzed
Some studies suggest metformin can be beneficial and should be continued for various conditions, while other studies indicate it may need to be discontinued before surgery or if outdated guidelines limit its use.
Not enough predictions.
The Consensus Meter needs at least 5 yes/no predictions to display. Try asking a popular research question.
Research summarized with Copilot
Beta19 papers analyzed
Can I Stop Taking Metformin?
Introduction to Metformin and Its Use in Diabetes Management
Metformin is a widely prescribed medication for managing type 2 diabetes mellitus (T2DM). It helps control blood sugar levels and has additional benefits such as improving lipid profiles and reducing microvascular and macrovascular complications. However, patients often question whether they can or should stop taking metformin, especially when facing certain health conditions or undergoing specific medical procedures.
Safety of Continuing Metformin with Mild Renal Impairment
Traditionally, metformin use has been contraindicated in patients with renal impairment due to concerns about lactic acidosis. However, recent studies suggest that patients with mild renal impairment (serum creatinine levels up to 220 µmol/l) can safely continue metformin without an increased risk of lactic acidosis. This finding is significant as stopping metformin in these patients often leads to poorer glycemic control and the need for alternative medications with their own side effects.
Impact of Metformin Discontinuation on Metabolic Control
Discontinuing metformin can lead to a deterioration in metabolic control. For instance, a study on clozapine-treated patients with schizophrenia found that stopping metformin resulted in a return to baseline body weight and metabolic abnormalities, which had been improved during metformin treatment. Similarly, in the Diabetes Prevention Program (DPP), stopping metformin led to a higher incidence of diabetes diagnosis compared to those who continued the medication, although some benefits persisted even after discontinuation.
Metformin and Cardiovascular Benefits
Early treatment with metformin has been associated with reduced cardiovascular morbidity and mortality in newly diagnosed T2DM patients. This benefit underscores the importance of maintaining metformin therapy, especially in patients at risk of cardiovascular events.
Gut-Based Pharmacology of Metformin
Metformin's effects extend beyond glucose reduction, involving complex gut-based mechanisms. Withdrawal of metformin has been shown to reduce levels of active and total GLP-1 and increase serum bile acids, which are reversed upon restarting the medication. These findings highlight the multifaceted role of metformin in managing T2DM and suggest that stopping the drug could disrupt these beneficial gut-based effects.
Perioperative Considerations
Metformin should be temporarily discontinued before surgery to avoid the risk of lactic acidosis, a serious perioperative complication. It is generally recommended to stop metformin 48 hours prior to surgery and resume it postoperatively once renal function is confirmed to be normal.
Conclusion
In summary, while there are specific situations where stopping metformin is necessary, such as before surgery, most patients with T2DM who tolerate the drug well should continue its use. Discontinuing metformin can lead to poorer glycemic control, weight gain, and a return of metabolic abnormalities. Patients with mild renal impairment can often safely continue metformin, and its cardiovascular and gut-based benefits further support its continued use. Always consult with a healthcare provider before making any changes to your medication regimen.
Sources and full results
Most relevant research papers on this topic
